medwireNews articles

ESMO 2018 Congress

ESMO 2018

Find all medweireNews articles about results presented during the congress.

Date Title Topic
02 Nov 2018 First-Line Pembrolizumab Plus Platinum-Based Chemotherapy ‘Standard Of Care’ For Advanced HNSCC Anticancer Agents - Immunotherapy - Head and Neck Cancers
30 Oct 2018 Cisplatin Superior To Cetuximab For Low-Risk, HPV-Positive Oropharyngeal Cancer Anticancer Agents - Head and Neck Cancers - Radiation Oncology
29 Oct 2018 PALOMA-3 OS Results Add Support For Palbociclib Use In Advanced Breast Cancer Anticancer Agents - Breast Cancer
26 Oct 2018 Avelumab Plus Axitinib ‘New First-Line Standard Of Care’ For Advanced RCC Anticancer Agents - Immunotherapy
25 Oct 2018 Trifluridine–Tipiracil Improves Metastatic Gastric Cancer OS Anticancer Agents - Gastric Cancer
24 Oct 2018 Olaparib Maintenance ‘Substantial Benefit’ For Advanced BRCA-Positive Ovarian Cancer Anticancer Agents - Ovarian Cancer - Personalised/Precision Medicine
23 Oct 2018 Low Metastatic Burden May Point to Radiation Benefit For Newly Diagnosed Prostate Cancer Prostate Cancer - Anticancer Agents - Radiation Oncology
21 Oct 2018 Atezolizumab Plus Nab-Paclitaxel Boost Metastatic Triple-Negative Breast Cancer Survival Anticancer Agents - Breast Cancer - Immunotherapy
20 Oct 2018 Serum Analysis Confirms Poor Tamoxifen Adherence Among Premenopausal Breast Cancer Patients Anticancer Agents - Breast Cancer